Skip to content

Methamphetamine-Fentanyl Polysubstance Administration Produces Social Deficits and Corticolimbic Stress-Reward Circuit Adaptations.

Leah M Salinsky, Joshua L Fox, Kyra C Diaz, Bradley C Timmons, Susan M Ferguson

Research square April 23, 2026 Peer reviewed DOI: 10.21203/rs.3.rs-9306429/v1 via PubMed

Summary

Repeated treatment with methamphetamine and fentanyl in rats led to reduced social preference during withdrawal, confirming previous findings of social dysfunction. Psilocybin treatment did not restore sociability after withdrawal. Additionally, the study found that the expression of stress- and opioid-related genes, CRHR1 and OPRM1, showed region- and sex-dependent changes in the medial prefrontal cortex and nucleus accumbens following polysubstance treatment.

Study at a glance

Design experimental study
Population male and female rats
Key finding Withdrawal from methamphetamine-fentanyl polysubstance treatment reduces social preference, with psilocybin treatment not restoring sociability.

Abstract

Polysubstance use involving psychostimulants and opioids is increasingly prevalent and associated with elevated overdose risk, relapse vulnerability, and poor treatment outcomes. However, the neurobehavioral consequences of opioid-stimulant use remain poorly understood. We evaluated whether repeated methamphetamine-fentanyl polysubstance treatment disrupts social preference during withdrawal, whether psilocybin treatment restores sociability, and whether these manipulations alter corticolimbic expression of stress- and opioid-related genes. Male and female rats received injections of methamphetamine and fentanyl or saline and were assessed for social preference at baseline and following 10 days of withdrawal. On withdrawal day 10, rats received psilocybin or saline and were reassessed for sociability 24 h later. CRHR1 and OPRM1 expression in the medial prefrontal cortex (mPFC) and nucleus accumbens (NAc) were quantified by RT-qPCR. Withdrawal from 14-days of polysubstance treatment reduced social preference, replicating prior findings of withdrawal-associated social dysfunction. Psilocybin pretreatment did not restore social preference at the time point examined. In the mPFC, psilocybin bidirectionally altered CRHR1 expression depending on drug history, decreasing expression in saline-treated controls, while increasing expression following polysubstance treatment. In the NAc, polysubstance administration reduced CRHR1 expression. OPRM1 expression showed sex-dependent regulation with a marked reduction in the NAc of females following polysubstance treatment and evidence of sex-dependent effects in the mPFC. Methamphetamine-fentanyl treatment produces persistent social deficits during withdrawal and region- and sex-dependent corticolimbic transcriptional adaptations in vivo. Although psilocybin did not restore sociability, it produced drug history-dependent regulation of cortical CRHR1.

Tags

Comments

No comments yet.

Log in to comment